Tech · Trending · 1 source
▼ Negative
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Headline via Ars Technica · First reported 9h ago · Updated 9h ago
Markers released top-line results today after previously reporting the trial succeeded.
